SNP-610: Clinical Trials

1 trial of SNP-610, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow SNP-610: new trials by email Literature Review of SNP-610 trials Research Report on SNP-610

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis
SNP-610, Placebo Oral Tablet - NASH - Nonalcoholic Steatohepatitis
Phase 2Not yet recruitingSinew Pharma Inc.802026-04-012026-03-18

Conditions studied

Non-alcoholic Fatty Liver Disease (1)

Sponsors

Sinew Pharma Inc. (1)